Cordlife Pte Ltd is a Singapore-registered company in the business of stem cell banking service, R&D and regenerative biomedical therapeutics. The company is committed to providing the highest quality stem cell treatment options for cancer, blood/ genetics diseases, immune deficiencies, neurological diseases and tissue regeneration.
The company has established a strong position in its core banking business through its Stem Cell Banking Division with operated facilities in Singapore, Malaysia and China; other sales and marketing offices in the region currently under development includes India, Indonesia, Taiwan, Korea, Thailand and the Philippines.

Cordlife's R&D Division has patent in ex-vivo stem cell expansion/amplification, and is currently pursuing three other areas of cell related biotechnology development towards supporting the Stem Cell Banking & Therapeutic Divisions.

The company's Therapeutic Division is focused on the development of application specific transplant centres using such stem cell therapies. Cordlife is currently developing this business in China, Singapore, Malaysia and Thailand.